Imugene Limited (ASX:IMU)

Leslie Chong
CEO
Market Cap (AUD): 79.42M
Sector: Health Care
Last Trade (AUD): 0.021 +-0 (+-4.55%)
Tab Bar

1. About

Imugene Limited is an Australian biopharmaceutical company developing HER-2+ gastric and breast cancer immunotherapies. The Company’s lead product is HER-Vaxx, a proprietary therapeutic cancer immunotherapy that stimulates a polyclonal antibody response to HER-2/neu, the same biomarker targeted by the $US6.9 billion per annum drug Herceptin.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk